Dr. Yonker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13123 E 16th Ave
Aurora, CO 80045Phone+1 720-777-1234
Summary
- Marcy Yonker, MD, is a pediatric headache specialist in Child Neurology based in Aurora, CO, . She obtained her MD from the University of Pittsburgh School of Medicine and completed her residency and fellowship at the Children's Hospital of Philadelphia. In addition to her clinical work, Dr. Yonker has contributed to several publications, predominantly around sleep disorders, pain syndromes, and migraines in pediatrics. Her involvement in clinical trials include studies for treatments of Pediatric Migraine and Chronic Migraine in adolescents, among others. She has been recognized for her work, receiving honors such as the Francescon Endowed Chair in Headache Treatment and being named as a Top Doctor in Arizona State by Castle Connolly.
Education & Training
- Children's Hospital of PhiladelphiaFellowship, Child Neurology, 1992 - 1995
- Children's Hospital of PhiladelphiaResidency, Pediatrics, 1990 - 1992
- University of Pittsburgh School of MedicineClass of 1990
Certifications & Licensure
- CO State Medical License 2017 - 2025
- AZ State Medical License 2008 - 2018
- DE State Medical License 1999 - 2009
- NJ State Medical License 2001 - 2009
- PA State Medical License 1992 - 2008
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- UCNSHeadache Medicine
Awards, Honors, & Recognition
- Francescon Endowed Chair in Headache Treatment Children's Colorado, 2017
- Top Doctors:Arizona State Castle Connolly, 2013
Clinical Trials
- The Childhood and Adolescent Migraine Prevention Study Start of enrollment: 2012 Jun 01
- Safety and Efficacy of Nerivio™ for the Acute Treatment of Migraine in Adolescents Start of enrollment: 2019 Oct 01
- A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine Start of enrollment: 2020 Nov 25
- Join now to see all
Publications & Presentations
PubMed
- 119 citationsUse of the ICHD-II Criteria in the Diagnosis of Pediatric MigraineAndrew D. Hershey, Paul Winner, Marielle A. Kabbouche, Jack Gladstein, Marcy Yonker
Headache. 2005-11-01 - 85 citationsPractice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Su...Maryam Oskoui, Tamara Pringsheim, Lori Billinghurst, Sonja Potrebic, Elaine M. Gersz
Neurology. 2019-09-10 - 6 citationsTelemedicine in Pediatric Headache: A Review and Practical ImplementationScott Rosenthal, Marcy Yonker
Current Neurology and Neuroscience Reports. 2021-04-12
Press Mentions
- Exploring the Link Between Pediatric Migraine & Sleep DisordersJune 22nd, 2020
- Could Your Child Have Migraines? - US NewsMarch 16th, 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: